secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001193125-25-189841
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aptose Biosciences enters retention agreements with CEO, CFO, and CMO totaling ~$698K upon change of control
--------------------------------------------------------------------------------

- CEO William Rice receives $331,496 retention grant; CFO Fletcher Payne $167,059; CMO Rafael Bejar $199,947.
- Payments due within 5 days of a change of control closing.
- Grants forfeited if executive is not actively employed at change of control closing.
- Aims to reward, retain, and incentivize leadership team for long-term shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525189841/0001193125-25-189841-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525189841/d50849d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-189841

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer